Skip to main content

Table 3 Summary of data from Figure 2A and 2B

From: Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression

Variable

Control

All Patients

Early

Late

Recurrent

Number of samples (n)

30

56

16

29

11

GPX3 concentration (ng/ml)

     

Median

36.1

21.4

31.7

18.5

14.7

Maximum

53.7

49.5

49.5

44.6

33.4

Minimum

9.9

4.5

20.5

4.5

7.7

Statistical Analysis: Mann Whitney U test (p-value)

     

Vs. Controls

 

3 × 10 -4

0.5

1 × 10 -4

7 × 10 -4

Vs. Early stage samples

   

5 × 10 -4

1 × 10 -3

  1. Comparison of samples ≥ 50 years indicates that GPX3 levels significantly decrease in patients and are correlated with stage with an even greater statistical significance than that seen in Table 1. p-values indicating statistically significant differences are shown in bold.